GENFIT Share Price OTC Markets
Stocks
GNFTF
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.95 USD | +48.37% |
|
0.00% | +165.83% |
| 03/07 | Genfit soars on news of U.S. reimbursement for a product |  |
| 03/07 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 66Cr 75Cr 61Cr 57Cr 106.02Cr 7.19TCr 107.84Cr 729.49Cr 285.53Cr 3.56TCr 282.47Cr 276.37Cr 12TCr | P/E 2026 * |
34.1x | P/E 2027 * | 87.6x |
|---|---|---|---|---|---|
| Enterprise Value | 61Cr 69Cr 57Cr 52Cr 98Cr 6.63TCr 99Cr 673.02Cr 263.43Cr 3.29TCr 260.6Cr 254.98Cr 11TCr | EV / Sales 2026 * |
6.08x | EV / Sales 2027 * | 4.79x |
| Free-Float |
86.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +48.37% | ||
| Current month | +48.37% | ||
| 1 month | +48.37% | ||
| 3 months | +44.34% | ||
| 6 months | +165.83% | ||
| Current year | +165.83% |
| 1 month | 15.95 |  | 15.95 |
| Current year | 7.26 | | 15.95 |
| 1 year | 4.14 | | 15.95 |
| 3 years | 2.95 | | 15.95 |
| 5 years | 2.95 | | 15.95 |
| 10 years | 0 | | 36.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +48.37% | 0.00% | - | - | 75Cr | |
| +0.14% | -0.67% | -0.88% | +11.02% | 4.79TCr | |
| -2.24% | +0.31% | +393.45% | +615.13% | 3.91TCr | |
| +1.40% | +3.69% | +12.21% | +46.79% | 3.67TCr | |
| +13.94% | +20.49% | +22.85% | +7.42% | 4.05TCr | |
| -0.73% | +3.38% | +4.94% | +41.45% | 2.8TCr | |
| +0.40% | -0.30% | - | - | 1.68TCr | |
| -3.12% | +7.39% | +26.03% | +124.08% | 1.59TCr | |
| +2.39% | -1.64% | +4.74% | +9.95% | 1.36TCr | |
| +6.79% | +8.17% | -4.97% | -28.52% | 1.38TCr | |
| Average | +6.73% | +4.64% | +57.30% | +103.42% | 2.8TCr | |
| Weighted average by Cap. | +2.51% | +5.03% | +73.29% | +125.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 11Cr 9.33Cr 8.58Cr 16Cr 1.09TCr 16Cr 110.69Cr 43Cr 540.94Cr 43Cr 42Cr 1.87TCr | 12Cr 14Cr 12Cr 11Cr 20Cr 1.35TCr 20Cr 137.04Cr 54Cr 669.7Cr 53Cr 52Cr 2.31TCr |
| Net income | 2.29Cr 2.61Cr 2.13Cr 1.96Cr 3.67Cr 249.05Cr 3.74Cr 25Cr 9.89Cr 123.51Cr 9.79Cr 9.58Cr 426.74Cr | 68L 77.48L 63.32L 58.24L 1.09Cr 74Cr 1.11Cr 7.51Cr 2.94Cr 37Cr 2.91Cr 2.85Cr 126.84Cr |
| Net Debt | -5.11Cr -5.82Cr -4.76Cr -4.38Cr -8.21Cr -556.47Cr -8.35Cr -56Cr -22Cr -275.97Cr -22Cr -21Cr -953.48Cr | -6.62Cr -7.54Cr -6.16Cr -5.67Cr -11Cr -720.37Cr -11Cr -73Cr -29Cr -357.25Cr -28Cr -28Cr -1.23TCr |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- GNFTF Stock
Select your edition
All financial news and data tailored to specific country editions
